{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:50:56Z","timestamp":1782831056128,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970804"],"award-info":[{"award-number":["81970804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770691"],"award-info":[{"award-number":["81770691"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170759"],"award-info":[{"award-number":["82170759"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110589","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T06:30:42Z","timestamp":1688538642000},"page":"110589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1575-7340","authenticated-orcid":false,"given":"Guochun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7428-9410","authenticated-orcid":false,"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110589_b0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.intimp.2023.110589_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41572-020-0196-7","article-title":"Podocytopathies","volume":"6","author":"Kopp","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.intimp.2023.110589_b0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2023.110589_b0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","article-title":"Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse","volume":"10","author":"Yap","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0025","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1523-1755.2005.00664.x","article-title":"Renal macrophage activation and Th2 polarization precedes the development of nephrotic syndrome in Buffalo\/Mna rats","volume":"68","author":"Le Berre","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.110589_b0030","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0035","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00467-011-1947-1","article-title":"Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives","volume":"27","author":"Elie","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0040","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: a long-term follow-up","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.110589_b0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.intimp.2023.110589_b0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJM198402163100702","article-title":"Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy","volume":"310","author":"Feehally","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110589_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000085357","article-title":"Changes of lymphocyte populations in pediatric steroid-sensitive nephrotic syndrome are more pronounced in remission than in relapse","volume":"25","author":"Kemper","year":"2005","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0060","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00467-009-1194-x","article-title":"The prevalence of Th17 cells and FOXP3 regulate T cells (Treg) in children with primary nephrotic syndrome","volume":"24","author":"Shao","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0065","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","article-title":"T regulatory cell function in idiopathic minimal lesion nephrotic syndrome","volume":"24","author":"Araya","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","article-title":"Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome","volume":"139","author":"Liu","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0075","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2215\/CJN.11941115","article-title":"T lymphocyte activation markers as predictors of responsiveness to rituximab among patients with FSGS","volume":"11","author":"Chan","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.intimp.2023.110589_b0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/ped.13255","article-title":"Regulatory T cells and CTLA-4 in idiopathic nephrotic syndrome","volume":"59","author":"Tsuji","year":"2017","journal-title":"Pediatrics Int.: Off. J. Jpn. Pediat. Soc."},{"key":"10.1016\/j.intimp.2023.110589_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fped.2019.00114","article-title":"Pediatric patients with steroid-sensitive nephrotic syndrome have higher expression of T regulatory lymphocytes in comparison to steroid-resistant disease","volume":"7","author":"Guimaraes","year":"2019","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.intimp.2023.110589_b0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1681\/ASN.2007111244","article-title":"Induction of T regulatory cells attenuates idiopathic nephrotic syndrome","volume":"20","author":"Le Berre","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111285","article-title":"LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity","volume":"9","author":"Bertelli","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2023.110589_b0100","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1681\/ASN.2011111130","article-title":"IL-2\/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD","volume":"23","author":"Polhill","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.trsl.2021.03.019","article-title":"Low regulatory T-cells: a distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy","volume":"235","author":"Chan","year":"2021","journal-title":"Transl. Res.: J. Lab. Clin. Med."},{"key":"10.1016\/j.intimp.2023.110589_b0110","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00467-009-1119-8","article-title":"Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"24","author":"Hashimura","year":"2009","journal-title":"Pediatric Nephrol."},{"key":"10.1016\/j.intimp.2023.110589_b0115","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nri3701","article-title":"Integrating canonical and metabolic signalling programmes in the regulation of T cell responses","volume":"14","author":"Pollizzi","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0120","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110589_b0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2010.11.024","article-title":"An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness","volume":"33","author":"Procaccini","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110589_b0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.110589_b0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-03231-w","article-title":"AIM2 in regulatory T cells restrains autoimmune diseases","volume":"591","author":"Chou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110589_b0145","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.4049\/jimmunol.1601251","article-title":"mTOR signaling regulates protective activity of transferred CD4+Foxp3+ T cells in repair of acute kidney injury","volume":"197","author":"Chen","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0150","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.kint.2021.08.023","article-title":"The semaphorin 4A-neuropilin 1 axis alleviates kidney ischemia reperfusion injury by promoting the stability and function of regulatory T cells","volume":"100","author":"Xu","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.110589_b0155","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2013application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.110589_b0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.kint.2019.02.020","article-title":"Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease","volume":"96","author":"Chen","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.110589_b0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/imr.12935","article-title":"Transcriptional regulation of adaptive and innate lymphoid lineage specification","volume":"300","author":"Spinner","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110589_b0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110589_b0175","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110589_b0180","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.4049\/jimmunol.173.12.7259","article-title":"CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion","volume":"173","author":"Curotto de Lafaille","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ni.2554","article-title":"Regulatory T cells: recommendations to simplify the nomenclature","volume":"14","author":"Abbas","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110589_b0195","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.110589_b0200","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20030686","article-title":"Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state","volume":"198","author":"Fisson","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110589_b0205","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1172\/JCI120859","article-title":"Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted","volume":"128","author":"Tilstra","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.110589_b0210","article-title":"An emerging role of TIM3 expression on T cells in chronic kidney inflammation","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115551","article-title":"Activation of CD3 + TIM3 + T cells contributes to excessive inflammatory response during glucocorticoid treatment","volume":"212","author":"Liu","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110589_b0220","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature23665","article-title":"Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling","volume":"548","author":"Yang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110589_b0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.12845","article-title":"mTOR signaling at the crossroads of environmental signals and T-cell fate decisions","volume":"295","author":"Huang","year":"2020","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.110589_b0230","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.110589_b0235","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.177.2.944","article-title":"Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells","volume":"177","author":"Valmori","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0240","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/s41467-018-04392-5","article-title":"mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis","volume":"9","author":"Chapman","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.110589_b0245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4049\/jimmunol.1701477","article-title":"mTOR complex 1 signaling regulates the generation and function of central and effector Foxp3(+) regulatory T cells","volume":"201","author":"Sun","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.110589_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115503","article-title":"Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway","volume":"211","author":"Chen","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110589_b0255","first-page":"20","article-title":"Context-dependent effect of glucocorticoids on the proliferation, differentiation, and apoptosis of regulatory T cells: a review of the empirical evidence and clinical applications","author":"Cari","year":"2019","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:10:20Z","timestamp":1777619420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":51,"alternative-id":["S1567576923009141"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110589","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110589"}}